Sign in
4

Changes in Ownership

GUIDED THERAPEUTICS INC Filed Acc 0001477932-25-002818

Director bought 1,263,355 shares at $0.10 ($126,307)

  • Director acquired 7,966,555 shares (other)
  • Director disposed of 2,986.75 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Imhoff John E Director 2025-03-06 Other disposition −300 0 D: show line 1 in the form
Imhoff John E Director 2025-03-06 Other acquisition +900,000 9,662,756 D: show line 2 in the form
Imhoff John E Director 2025-03-06 Other disposition −2,400.75 0 D: show line 3 in the form
Imhoff John E Director 2025-03-06 Other acquisition +4,801,500 $0.50 $2,400,750 14,464,256 D: show line 4 in the form
Imhoff John E Director 2025-03-07 Purchase +286 286 D: show line 5 in the form
Imhoff John E Director 2025-03-11 Other disposition −286 0 D: show line 6 in the form
Imhoff John E Director 2025-03-11 Other acquisition +2,258,690 $0.13 $285,950 16,722,946 D: show line 7 in the form
Imhoff John E Director 2025-03-18 Purchase +1,000,000 $0.10 $100,000 17,722,946 D: show line 8 in the form
Imhoff John E Director 2025-03-18 Purchase +263,069 $0.10 $26,307 17,986,015 D: show line 9 in the form
Imhoff John E Director 2025-04-10 Other acquisition +6,365 17,992,380 D: show line 10 in the form
Open-market purchases · 1,263,355 sh · avg $0.10 · $126,307

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Imhoff John E Director 2025-03-18 Purchase · Warrants +1,000,000 1,000,000 D: show line 11 in the form
Imhoff John E Director 2025-03-18 Purchase · Warrants +263,069 1,263,069 D: show line 12 in the form
Loading xslF345X05/form4.xml…